| Dr Timothy O'donnell, DO | |
|
63 Beaverbrook Rd Ste 301, Lincoln Park, NJ 07035-1440 | |
| (973) 694-1300 | |
| (973) 694-1399 |
| Full Name | Dr Timothy O'donnell |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 39 Years |
| Location | 63 Beaverbrook Rd Ste 301, Lincoln Park, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841239050 | NPI | - | NPPES |
| 538110 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 25MB04853800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chilton Medical Center | Pompton plains, NJ | Hospital |
| Valley Hospital | Ridgewood, NJ | Hospital |
| St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Physician Services Pc | 3577857333 | 402 |
News Archive
Preliminary findings from a mass participation study have indicated a link between weather conditions - specifically rain and lack of sunshine - and chronic pain.
Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
Elixir Pharmaceuticals, Inc. announced today that its partner, Siena Biotech S.p.A., has commenced Phase 1 clinical testing of Elixir's potent, first-in-class SIRT1 (sirtuin-1) inhibitor for the treatment of Huntington's Disease.
"The Obama administration's new Global Health Initiative, designed to broaden and better integrate health programming overseas, deserves wide support. But stalling on global AIDS threatens to undermine the worthy goals of the initiative," Chris Collins, vice president and director of public polity for the Foundation for AIDS Research, writes in a Boston Globe letter to the editor calling for sustained support for PEPFAR.
› Verified 9 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Preliminary findings from a mass participation study have indicated a link between weather conditions - specifically rain and lack of sunshine - and chronic pain.
Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
Elixir Pharmaceuticals, Inc. announced today that its partner, Siena Biotech S.p.A., has commenced Phase 1 clinical testing of Elixir's potent, first-in-class SIRT1 (sirtuin-1) inhibitor for the treatment of Huntington's Disease.
"The Obama administration's new Global Health Initiative, designed to broaden and better integrate health programming overseas, deserves wide support. But stalling on global AIDS threatens to undermine the worthy goals of the initiative," Chris Collins, vice president and director of public polity for the Foundation for AIDS Research, writes in a Boston Globe letter to the editor calling for sustained support for PEPFAR.
› Verified 9 days ago
| Entity Name | Valley Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467815928 PECOS PAC ID: 3577857333 Enrollment ID: O20160802002824 |
News Archive
Preliminary findings from a mass participation study have indicated a link between weather conditions - specifically rain and lack of sunshine - and chronic pain.
Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
Elixir Pharmaceuticals, Inc. announced today that its partner, Siena Biotech S.p.A., has commenced Phase 1 clinical testing of Elixir's potent, first-in-class SIRT1 (sirtuin-1) inhibitor for the treatment of Huntington's Disease.
"The Obama administration's new Global Health Initiative, designed to broaden and better integrate health programming overseas, deserves wide support. But stalling on global AIDS threatens to undermine the worthy goals of the initiative," Chris Collins, vice president and director of public polity for the Foundation for AIDS Research, writes in a Boston Globe letter to the editor calling for sustained support for PEPFAR.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy O'donnell, DO 63 Beaverbrook Rd Ste 301, Lincoln Park, NJ 07035-1440 Ph: (973) 694-1300 | Dr Timothy O'donnell, DO 63 Beaverbrook Rd Ste 301, Lincoln Park, NJ 07035-1440 Ph: (973) 694-1300 |
News Archive
Preliminary findings from a mass participation study have indicated a link between weather conditions - specifically rain and lack of sunshine - and chronic pain.
Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
Elixir Pharmaceuticals, Inc. announced today that its partner, Siena Biotech S.p.A., has commenced Phase 1 clinical testing of Elixir's potent, first-in-class SIRT1 (sirtuin-1) inhibitor for the treatment of Huntington's Disease.
"The Obama administration's new Global Health Initiative, designed to broaden and better integrate health programming overseas, deserves wide support. But stalling on global AIDS threatens to undermine the worthy goals of the initiative," Chris Collins, vice president and director of public polity for the Foundation for AIDS Research, writes in a Boston Globe letter to the editor calling for sustained support for PEPFAR.
› Verified 9 days ago
Martin Jahes Corso, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 29 Station Rd, Lincoln Park, NJ 07035 Phone: 973-628-8442 Fax: 973-628-9516 | |
Dr. Anju Budhwani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 166 Main St Ste 1a, Lincoln Park, NJ 07035 Phone: 973-694-6260 Fax: 973-694-2359 |